Research progress of magnesium ion and its transporters in tumors
10.3781/j.issn.1000-7431.2020.55.876
- Author:
Yongsheng HUANG
1
Author Information
1. Department of General Surgery, ZhuJiang Hospital of Southern Medical University
- Publication Type:Journal Article
- Keywords:
Cation transport proteins;
CNNM;
Magnesium;
MagT;
Neoplasms;
SLC;
TRPM
- From:
Tumor
2020;40(5):371-376
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, researchers have found that magnesium ion homeostasis imbalance is common in tumor cells, and the deficiency and supplement of magnesium ion can affect the occurrence and development of tumor. As an abundant divalent cation in cells, magnesium ion plays an important role in maintaining genetic stability, metabolism, cell growth and proliferation, signal transduction and other physiological processes. Magnesium ion homeostasis is regulated by a variety of transporters, and the research reports on the changes of magnesium ion transporters expression leading to the imbalance of magnesium ion homeostasis which affects the occurrence, development and treatment prognosis of tumors are increasing year by year. In this article, magnesium ion and its related transport proteins include magnesium ion transient receptor potential melastatin (TRPM) protein, magnesium transporter (MagT) protein, cyclin and cystathionine beta-synthase (CBS) domain divalent metal cation transport mediator (CNNM) protein and solute carrier (SLC) protein and other related reports in tumors are summarized, with the purpose of providing ideas for exploring whether magnesium ion and its transporters can become new targets for tumor diagnosis, treatment and prognosis.
